65755-34-2Relevant academic research and scientific papers
Synthesis of cis-2-alkoxycyclopropylamines via intramolecular cyclization of 2-azaallylic anions derived from alkoxybrominated N-(arylidene)-2-methyl-2- propenylamines
Mangelinckx, Sven,Kadam, Santosh T.,Semina, Elena,Callebaut, Gert,Colpaert, Filip,De Smaele, Dirk,De Kimpe, Norbert
, p. 3728 - 3735 (2013/05/09)
N-(Arylidene)-2-alkoxy-3-bromo-2-methylpropylamines, obtained in a straightforward way via regiospecific alkoxybromination of the corresponding N-(2-methyl-2-propenyl)imines, represent promising densely functionalized synthetic building blocks. The substi
Rhodium-catalysed hydroformylation of N-(2-propenyl)-β-lactams as a key step in the synthesis of functionalised N-[4-(2-oxoazetidin-1-yl)but-1-enyl] acetamides
Dekeukeleire, Stijn,D'Hooghe, Matthias,Mueller, Christian,Vogt, Dieter,De Kimpe, Norbert
body text, p. 1079 - 1083 (2010/08/08)
Biologically relevant functionalised N-[4-(2-oxoazetidin-1-yl)-but-1-enyl] acetamides have been prepared in a two-step approach starting from N-(2-propenyl)-β-lactams, involving initial rhodium-catalysed hydroformylation followed by subjection of the obta
THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS
-
Page/Page column 127, (2008/06/13)
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein w, R1, q, p, R2, t, Ar1, L1, R3 and R4 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
